Literature DB >> 17425733

Functional MRI in multiple sclerosis.

Maria A Rocca1, Massimo Filippi.   

Abstract

There is increasing evidence that the severity of the clinical manifestations of multiple sclerosis (MS) does not simply depend on the extent of tissue destruction, but rather represents a complex balance among tissue damage, tissue repair, and cortical reorganization. Functional magnetic resonance imaging (fMRI) provides information about the extent and nature of brain plasticity, which follows MS structural injury and might have the potential to limit the clinical manifestations of the disease. An altered recruitment of regions normally devoted to the performance of a given task and/or the recruitment of additional areas, which are not typically activated by healthy people for performing that given task, have been described in patients with MS, independent of their clinical phenotype when investigating the visual, cognitive, and motor systems. These functional changes have been related to the extent and severity of brain damage within and outside T2-visible lesions and to the involvement of specific central nervous system (CNS) structures, including the spinal cord and the optic nerve. Brain functional changes have been shown to be dynamic over time, not only after an acute relapse, but also in clinically stable patients. An increased recruitment of the cerebral networks might represent a first step of cortical reorganization with the potential to maintain a normal level of function in the course of MS. The progressive failure of these mechanisms might, on the one hand, result in the activation of previously silent "second-order" compensatory areas, and, on the other, contribute to the clinical manifestations of the disease.

Entities:  

Mesh:

Year:  2007        PMID: 17425733     DOI: 10.1111/j.1552-6569.2007.00135.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  27 in total

Review 1.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

2.  Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?

Authors:  Maria A Rocca; Martina Absinta; Angelo Ghezzi; Lucia Moiola; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

3.  Influence of task complexity during coordinated hand and foot movements in MS patients with and without fatigue. A kinematic and functional MRI study.

Authors:  Maria Assunta Rocca; Roberto Gatti; Federica Agosta; Paola Broglia; Paolo Rossi; Elisa Riboldi; Manuela Corti; Giancarlo Comi; Massimo Filippi
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

Review 4.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

5.  Ipsilateral cortical fMRI responses after peripheral nerve damage in rats reflect increased interneuron activity.

Authors:  Galit Pelled; Debra A Bergstrom; Patrick L Tierney; Richard S Conroy; Kai-Hsiang Chuang; David Yu; David A Leopold; Judith R Walters; Alan P Koretsky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

6.  Functional MR imaging correlates of neuropsychological impairment in primary-progressive multiple sclerosis.

Authors:  M A Rocca; G Riccitelli; M Rodegher; A Ceccarelli; A Falini; M Falautano; A Meani; G Comi; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 7.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

Review 8.  Biomarkers of recovery after stroke.

Authors:  Marie-Hélène Milot; Steven C Cramer
Journal:  Curr Opin Neurol       Date:  2008-12       Impact factor: 5.710

9.  Immunopathogenesis of multiple sclerosis.

Authors:  Michael K Racke
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

10.  Functional brain network changes associated with maintenance of cognitive function in multiple sclerosis.

Authors:  Santosh A Helekar; Jae C Shin; Brandi J Mattson; Krystle Bartley; Milena Stosic; Toni Saldana-King; P Read Montague; George J Hutton
Journal:  Front Hum Neurosci       Date:  2010-11-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.